Genmab A/S | Key People and Executives
Daniel John Bruno
Non-Independent Director & VP-Controller
Richard Gordon Hibbert
Non-Independent Director
Peter Storm Kristensen
Non-Independent Director
Deirdre P. Connelly
Director
Anders Gersel Pedersen
Deputy Chairman
Mats Gunnar Pettersson
Chairman
Rolf K. Hoffmann
Member-Supervisory Board
Paolo Paoletti
Independent Director
Pernille Lyngvold Erenbjerg
Independent Director
Jan G. J. van de Winkel
President & Chief Executive Officer
David Andrew Eatwell
Chief Financial Officer & Executive Vice President
Paul W. H. I. Parren
Senior Vice President & Scientific Director
Judith Klimovsky
Chief Development Officer & Executive VP
Anthony Pagano
Senior Vice President-Global Finance
Michael K. Bauer
Senior Vice President-Clinical Development
Daniel John Bruno
Non-Independent Director & VP-Controller
Richard Gordon Hibbert
Non-Independent Director
Peter Storm Kristensen
Non-Independent Director
Deirdre P. Connelly
Director
Anders Gersel Pedersen
Deputy Chairman
Rachel Curtis Gravesen
Senior VP-Investor Relations & Communications
Birgitte Stephensen
Senior VP-Intellectual Property Rights & Legal
Mats Gunnar Pettersson
Chairman
Rolf K. Hoffmann
Member-Supervisory Board
Paolo Augusto Paoletti
Independent Director
Pernille Lyngvold Erenbjerg
Independent Director
| Address |
Kalvebod Brygge 43
Copenhagen CR 1560
Denmark
|
|
Employees
|
- |
| Website |
http://www.genmab.com |
| Updated |
07/08/2019 |
| Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer. Its antibody product, Arzerra used in the treatment of chronic lymphocytic leukemia indications; and DARZALEX. |
